Innoscience's stock experienced a significant intraday surge, soaring 5.00% during Tuesday's trading session.

The sharp rise appears driven by multiple positive catalysts. The company has completed the filing for its H-share full circulation application with the China Securities Regulatory Commission, a move expected to eliminate the "dual-class share" discount and optimize its corporate governance structure. Furthermore, management has projected total revenue for the current fiscal year to reach RMB 2.0 to 2.5 billion, representing year-over-year growth of 65% to 106%, with an expected gross margin improvement above 15%. Strong performance in its GaN chip business for AI and data center applications, with revenue up 50.2% year-over-year, and the full-scale mass production of its 3.0 process platform also contributed to positive investor sentiment.